Description
Palbociclib capsules are a targeted cancer therapy used to treat hormone receptor-positive, HER2-negative metastatic breast cancer in both men and women. They work by inhibiting cyclin-dependent kinases 4 and 6, which regulate cell division, thereby slowing cancer cell proliferation. Typically administered in combination with an aromatase inhibitor or fulvestrant.